World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
49
Citations
8633
World Ranking
4347
National Ranking
1976

Penelope A. Morel publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Penelope A. Morel sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 155 publications — 18th percentile

18% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Penelope A. Morel D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Penelope A. Morel sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 49 D-Index — 13th percentile

13% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Penelope A. Morel is affiliated with the University of Pittsburgh in the United States. Their research spans multiple disciplines including Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology. Within these domains, their work focuses notably on immunology, infectious diseases, molecular biology, oncology, and modeling and simulation.

The primary topics addressed in their publications include:

  • Immune Cell Function and Interaction
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • T-cell and B-cell Immunology
  • RNA Research and Splicing
  • COVID-19 Epidemiological Studies
  • Immune Cells in Cancer

Some of the frequent publication venues where Penelope A. Morel has contributed are:

  • The Journal of Immunology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • PLoS Pathogens
  • Cancer Research Communications
  • Immunometabolism

The following is a selection of recent papers authored or co-authored by Morel along with their year of publication and publication venues:

  • COVID-19 virtual patient cohort suggests immune mechanisms driving disease outcomes (2021), PLoS Pathogens
  • Iterative community-driven development of a SARS-CoV-2 tissue simulator (2020), bioRxiv (Cold Spring Harbor Laboratory)
  • COVID-19 virtual patient cohort reveals immune mechanisms driving disease outcomes (2021), bioRxiv (Cold Spring Harbor Laboratory)
  • Synergism Between IL21 and Anti-PD-1 Combination Therapy is Underpinned by the Coordinated Reprogramming of the Immune Cellular Network in the Tumor Microenvironment (2023), Cancer Research Communications
  • Alternatively Spliced Variants of Murine CD247 Influence T Cell Development and Activation, Revealing the Importance of the CD3ζ C-Terminal Region (2023), The Journal of Immunology

Collaborations are a substantial component of Morel's research activities. Frequent co-authors include:

  • Ye Jin
  • Adrianne L. Jenner
  • Courtney L. Davis
  • Amber M. Smith
  • Morgan Craig

Best Publications

  • In vivo imaging platform for tracking immunotherapeutic cells

    Eric T Ahrens;Rafael Flores;Hongyan Xu;Penelope A Morel

  • Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study.

    Penelope A. Morel;Janice S. Dorman;John A. Todd;Hugh O. McDevitt

  • Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function.

    Robbie B. Mailliard;Young Ik Son;Richard Redlinger;Patrick T. Coates

  • Fluorine-19 MRI for visualization and quantification of cell migration in a diabetes model.

    Mangala Srinivas;Penelope A. Morel;Lauren A. Ernst;David H. Laidlaw

  • Crossregulation between Th1 and Th2 cells.

    Penelope A. Morel;Timothy B. Oriss

  • Dendritic Cells Promote Macrophage Infiltration and Comprise a Substantial Proportion of Obesity-Associated Increases in CD11c+ Cells in Adipose Tissue and Liver

    Maja Stefanovic-Racic;Xiao Yang;Michael S. Turner;Benjamin S. Mantell

  • Receptor‐mediated endocytosis of iron‐oxide particles provides efficient labeling of dendritic cells for in vivo MR imaging

    E.T. Ahrens;M. Feili-Hariri;H. Xu;G. Genove

  • Immunotherapy of NOD mice with bone marrow-derived dendritic cells.

    Maryam Feili-Hariri;Xin Dong;Sean M. Alber;Simon C. Watkins

  • Dominant Role of Antigen Dose in CD4+Foxp3+ Regulatory T Cell Induction and Expansion

    Michael S. Turner;Lawrence P. Kane;Penelope A. Morel

  • T-bet and Eomesodermin Are Required for T Cell-Mediated Antitumor Immune Responses

    Yibei Zhu;Songguang Ju;Elizabeth Chen;Shao Dai

  • Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies.

    Terrance P. O'Hanlon;Danielle Mercatante Carrick;Ira N. Targoff;Frank C. Arnett

  • In vivo cytometry of antigen-specific t cells using 19F MRI.

    Mangala Srinivas;Michael S. Turner;Jelena M. Janjic;Penelope A. Morel

  • Negative regulation of FcϵRI signaling by FcγRII costimulation in human blood basophils

    Christopher L. Kepley;John C. Cambier;Penelope A. Morel;Don Lujan

  • Expression of Functional CD32 Molecules on Human NK Cells Is Determined by an Allelic Polymorphism of the FcγRIIC Gene

    Diana Metes;Linda K. Ernst;William H. Chambers;Andrei Sulica

  • Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy

    Maryam Feili-Hariri;Dewayne H. Falkner;Penelope A. Morel

  • Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis

    Patrizia Fuschiotti;Thomas A. Medsger;Penelope A. Morel

  • Co-aggregation of FcgammaRII with FcepsilonRI on human mast cells inhibits antigen-induced secretion and involves SHIP-Grb2-Dok complexes.

    Christopher L. Kepley;Sharven Taghavi;Graham A. Mackay;Daocheng Zhu

  • Crossregulation Between T Helper Cell (Th)1 and Th2: Inhibition of Th2 Proliferation by IFN-gamma Involves Interference With IL-1

    T B Oriss;S A McCarthy;B F Morel;M A Campana

  • FcγRIIa, Not FcγRIIb, Is Constitutively and Functionally Expressed on Skin-Derived Human Mast Cells

    Wei Zhao;Christopher L. Kepley;Penelope A. Morel;Lawrence M. Okumoto

  • The duration of T cell stimulation is a critical determinant of cell fate and plasticity.

    Natasa Miskov-Zivanov;Michael S. Turner;Lawrence P. Kane;Penelope A. Morel

  • Aspartic acid at position 57 of the DQ beta chain protects against type 1 diabetes: A family study

    P A Morel;J S Dorman;J A Todd;H O Mcdevitt

Frequent Co-Authors

David J. Tweardy
David J. Tweardy The University of Texas MD Anderson Cancer Center
Thomas A. Medsger
Thomas A. Medsger University of Pittsburgh
Ronald B. Herberman
Ronald B. Herberman University of Pittsburgh
Angus W. Thomson
Angus W. Thomson University of Pittsburgh
Leslie T. Cooper
Leslie T. Cooper Mayo Clinic
Frank C. Arnett
Frank C. Arnett The University of Texas Health Science Center at Houston
John D. Reveille
John D. Reveille The University of Texas Health Science Center at Houston
Lawrence P. Kane
Lawrence P. Kane University of Pittsburgh
Mary Carrington
Mary Carrington Ragon Institute of MGH, MIT and Harvard
John A. Todd
John A. Todd University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, related healthcare degrees offer valuable pathways to broaden expertise and enhance career opportunities. Many aspiring professionals consider programs like the easiest accelerated nursing programs to get into, which provide a quicker route to becoming a Registered Nurse while building strong clinical foundations relevant to immunology.

Additionally, those seeking practical and focused training might explore easy LPN programs to get into. Licensed Practical Nurses play essential roles in patient care and immune system monitoring, making this an accessible option for many learners.

For advanced specialization, pursuing an easiest nurse practitioner program online can open doors to leadership roles in healthcare settings, including immunology-focused teams.

Notably, mental health intersects with immunology in many ways. Online programs like the best online psychiatric mental health nurse practitioner programs offer unique clinical placements, preparing students to address complex patient needs holistically.

Best Scientists Citing Penelope A. Morel

Trending Scientists

Recently Published Articles